Related Experiment Video
Updated: Oct 21, 2025

07:17
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
1.4K
GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study
Deepali Jain1, Prerna Guleria1, Varsha Singh1
1Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Pathology Oncology Research : POR
|September 9, 2021
Summary
Racial and environmental factors do not alter the common GTF2I mutation in thymomas. However, these factors may influence the age and stage at diagnosis, and the frequency of myasthenia gravis (MG).
Area of Science:
- Oncology
- Genetics
- Epidemiology
Background:
- Thymomas are the most common adult cancers of the mediastinum, with unknown etiology and poorly understood pathogenesis.
- The influence of racial, ethnic, and environmental factors on thymoma tumorigenesis is unclear.
- The GTF2I gene mutation is a specific molecular feature of certain thymoma subtypes (A and AB).
Purpose of the Study:
- To compare the prevalence of the GTF2I gene mutation in thymoma patients from India and Germany.
- To analyze epidemiological differences, including age, tumor stage, and myasthenia gravis (MG) frequency, between Indian and German thymoma cohorts.
- To investigate the role of racial-ethnic and environmental factors in thymoma characteristics.
Main Methods:
- Retrospective analysis of pretreatment thymoma cases from India (n=37) and Germany (n=77).
- Comparison of GTF2I mutation prevalence (c.74146970T > A) in type A and AB thymomas.
- Assessment of epidemiological data: age, Masaoka-Koga tumor stage, and myasthenia gravis (MG) status.
Main Results:
- Histological type distribution was similar between Indian and German cohorts.
- Indian patients were significantly younger (median 50 vs. 65 years) and presented with lower tumor stage (Masaoka-Koga stage I) compared to German patients.
- A trend towards higher MG frequency was observed in Indian patients (48% vs. 82%), and the GTF2I mutation prevalence was identical across both cohorts.
Conclusions:
- Racial-ethnic and environmental factors do not significantly impact the GTF2I mutation prevalence in thymomas.
- These factors may influence the clinical presentation, including age at diagnosis, tumor stage, and the occurrence of myasthenia gravis.
- Further research is needed to elucidate the precise mechanisms underlying these observed epidemiological disparities.

